Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT01091142 · COMPLETED
Trial details
- NCT number
- NCT01091142
- Sponsor
- Neuraltus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2010-09-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.